Allergan expands Alzheimer’s campaign after expanding Namzaric indication – FiercePharma

November 21, 2016 by  
Filed under Alzheimers News

Sponsored By

FiercePharma
Allergan expands Alzheimer's campaign after expanding Namzaric indication
FiercePharma
With a newly expanded indication for Alzheimer's disease combination therapy Namzaric, Allergan has added new creative elements to an already running campaign. The expansion, approved in July, allows patients currently treated with Eisai's Aricept to …

More Info: Click here

Speak Your Mind

Tell us what you're thinking...
and oh, if you want a pic to show with your comment, go get a gravatar!

*